Roger C. Denton, Member of Schlichter, Bogard & Denton

Mr. Denton has devoted his legal career to representing individuals who have been seriously injured.  Mr. Denton has extensive experience litigating pharmaceutical products liability cases involving defective drugs and devices, representing thousands of clients.  By achieving record settlements and verdicts in multiple jurisdictions, he has also gained a national reputation as an accomplished trial attorney for litigation under the Federal Employers' Liability Act ("FELA) involving injured railroad employees.  Mr. Denton has significant litigation experience in complex cases of dangerous products, professional malpractice, and commercial litigation.  Mr. Denton has obtained numerous multi-million dollar verdicts and settlements against Fortune 500 companies and other corporations, building his reputation as an aggressive litigator and trial attorney.

Mr. Denton has not only been active in a number of mass tort actions, but has also served in several leadership roles in these actions.  In the Multi-District action, In Re Gadolinium-Based Contrast Products Liability Litigation, Mr. Denton was nominated by his peers for the Plaintiffs' National Steering Committee, a select group of lead plaintiffs' attorneys that direct and oversee this complex litigation.  His nomination was confirmed in April 2008 by United States District Judge Dan Polster.  Mr. Denton is also a member of the Science and Discovery Committees of the Gadolinium litigation.  He has also been a member of the PSC for In Re Ortho Evra Products Liability Litigation, and serves on the Science and Discovery Committees for that litigation as well.  He is also a part of the In Re Ortho Evra Products Liability Litigation trial team.  As a result of these important leadership roles, he has taken part in deposing executive level employees of Johnson & Johnson and developing expert witnesses in pharmacology, clinical studies, and regulatory issues under the Food and Drug Administration (FDA).

 Mr. Denton has been actively involved in many other mass tort litigations including major drug cases Fen-Phen, Vioxx®, and NuvaRing®.  He represents clients nationwide in many other defective drug cases and other personal injury cases.  Mr. Denton has published articles in legal journals and spoken at national seminars on pharmaceutical litigation and other areas of litigation.

Mr. Denton's "AV" rating in Martindale-Hubbell is the highest level available and represents the judgment of his peers about his professionalism, quality and expertise in legal work, and ethics.  Mr. Denton is a member of many distinguished professional affiliations, including:

• The American Association for Justice
• The Missouri Bar Association
• The Illinois Bar Association
• The Wisconsin Bar Association
• The Missouri Association of Trial Attorneys
• The Illinois Trial Lawyers Association

Mr. Denton graduated in 1978, cum laude, with a Bachelor of Arts Degree from Culver-Stockton College in Missouri.  He attended law school at St. Louis University School of Law, where he was a member of the Law Journal, and obtained his Juris Doctor in 1982, graduating summa cum laude.  He was admitted to practice law in 1982 in Illinois, in 1983 in Missouri, and in 1998 in Wisconsin.  He is also admitted to practice before the United Supreme Court, the United States Courts of Appeals for the Seventh and Eight Circuits, and the United States District Courts in Illinois, Indiana, Missouri, and Wisconsin.

Mr. Denton is a founding partner of Schlichter, Bogard & Denton.  He practices law in the St. Louis, Missouri office, where he is a managing partner, and in the Minocqua, Wisconsin office, where he is the sole managing partner.